These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 9296709)

  • 1. [Activation of transcription of interleukin-2 gene by nuclear factors from the spleen and brain of immunized rats].
    Kazakova TB; Grishina TV; Golovko OI; Gushchin GV; Miul'berg AA
    Biull Eksp Biol Med; 1994 May; 117(5):523-6. PubMed ID: 9296709
    [No Abstract]   [Full Text] [Related]  

  • 2. Transactivation of interleukin-2 gene via the nuclear proteins from spleen and brain cells.
    Kazakova TB; Golovko OI; Gushchin GV; Lebedeva LV; Dolgi OD; Karandaschov EA; Mulberg AA
    Biotechnol Ther; 1993; 4(1-2):63-76. PubMed ID: 8374513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular-biologic aspects of interaction between nervous and immune systems].
    Korneva EA; Golovko OI; Kazakova TV
    Vopr Med Khim; 1997; 43(5):321-9. PubMed ID: 9446322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF45/ILF2 tissue expression, promoter analysis, and interleukin-2 transactivating function.
    Zhao G; Shi L; Qiu D; Hu H; Kao PN
    Exp Cell Res; 2005 May; 305(2):312-23. PubMed ID: 15817156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors.
    Márquez N; Sancho R; Macho A; Calzado MA; Fiebich BL; Muñoz E
    J Pharmacol Exp Ther; 2004 Mar; 308(3):993-1001. PubMed ID: 14617683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A-resistant transactivation of the IL-2 promoter requires activity of okadaic acid-sensitive serine/threonine phosphatases.
    Nebl G; Meuer SC; Samstag Y
    J Immunol; 1998 Aug; 161(4):1803-10. PubMed ID: 9712047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
    Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
    Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for STAT5A/B in protection of peripheral T-lymphocytes from postactivation apoptosis: insights from gene expression profiling.
    Gatzka M; Piekorz R; Moriggl R; Rawlings J; Ihle JN
    Cytokine; 2006 May; 34(3-4):143-54. PubMed ID: 16757175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term estrogen treatment on IFN-gamma, IL-2 and IL-4 gene expression and protein synthesis in spleen and thymus of normal C57BL/6 mice.
    Karpuzoglu-Sahin E; Zhi-Jun Y; Lengi A; Sriranganathan N; Ansar Ahmed S
    Cytokine; 2001 May; 14(4):208-17. PubMed ID: 11448120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High mobility group box-1 protein acts as a coactivator of nuclear factor of activated T cells-2 in promoting interleukin-2 transcription.
    Liu H; Yao YM; Ding LH; Zhang H; Yuan B; Song Q; Ye QN; Huang CF; Sheng ZY
    Int J Biochem Cell Biol; 2009 Mar; 41(3):641-8. PubMed ID: 18707018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The increase in the induction of IL-2 expression with caloric restriction is correlated to changes in the transcription factor NFAT.
    Pahlavani MA; Harris MD; Richardson A
    Cell Immunol; 1997 Aug; 180(1):10-9. PubMed ID: 9316634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced basal AP-1 activity and de-regulation of numerous genes in T cells transgenic for a dominant interfering mutant of FADD/MORT1.
    Chaneva S; Schneider G; Siegmund D; Wajant H; Mages J; Häcker G
    Eur J Immunol; 2004 Nov; 34(11):3006-15. PubMed ID: 15376191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-2 induction by simian immunodeficiency virus involves MAP kinase signaling but is independent of calcineurin/NF-AT activity.
    Muckenfuss H; Hamdorf M; Avots A; Sanzenbacher R; Tschulena U; Cichutek K; Flory E
    Mol Immunol; 2006 Mar; 43(8):1172-82. PubMed ID: 16125242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.
    Schnaider T; Somogyi J; Csermely P; Szamel M
    Cell Stress Chaperones; 2000 Jan; 5(1):52-61. PubMed ID: 10701840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between high-mobility group box 1 protein release and T-cell suppression in rats after thermal injury.
    Zhang LT; Yao YM; Dong YQ; Dong N; Yu Y; Sheng ZY
    Shock; 2008 Oct; 30(4):449-55. PubMed ID: 18277947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of interleukin 2 in SLE T cells.
    Tenbrock K; Tsokos GC
    Int Rev Immunol; 2004; 23(3-4):333-45. PubMed ID: 15204092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone dynamics on the interleukin-2 gene in response to T-cell activation.
    Chen X; Wang J; Woltring D; Gerondakis S; Shannon MF
    Mol Cell Biol; 2005 Apr; 25(8):3209-19. PubMed ID: 15798206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Bcl-2 gene is differentially regulated by IL-2 and IL-4: role of the transcription factor NF-AT.
    Gómez J; Martínez-A C; González A; García A; Rebollo A
    Oncogene; 1998 Sep; 17(10):1235-43. PubMed ID: 9771966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2-dependent expression of genes involved in cytoskeleton organization, oncogene regulation, and transcriptional control.
    Herblot S; Chastagner P; Samady L; Moreau JL; Demaison C; Froussard P; Liu X; Bonnet J; Thèze J
    J Immunol; 1999 Mar; 162(6):3280-8. PubMed ID: 10092780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of anethole on T-lymphocyte proliferation and interleukin-2 production through down-regulation of the NF-AT and AP-1.
    Yea SS; Jeong HS; Choi CY; Park KR; Oh S; Shin JG; Yun CH
    Toxicol In Vitro; 2006 Oct; 20(7):1098-105. PubMed ID: 16531003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.